Simulations Plus, Inc. - Common Stock — movimiento de fondos (NASDAQ:SLP)

Financials

Visión general Informes Estadísticas Dividendos

Flujo de caja de las actividades operativas 10.91 M19.2 M17.9 M21.86 M13.32 M18.13 M 24.38 M Flujo de caja de las actividades de inversión -75.51 M-26.74 M4.3 M7.37 M-53.97 M3.56 M -10.23 M Flujo de caja de las actividades financieras 102.37 M-4.68 M-7.62 M-23.27 M-6.57 M-1.15 M 590 K Flujo de caja libre 8.33 M14.63 M13.93 M18.18 M9.56 M14.78 M 20.81 M

Simulations Plus, Inc. - Common Stock

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

SLP

Financials

Simulations Plus, Inc. - Common Stock

Noticias

PTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares Jump

Las acciones de Simulations Plus se disparan un 28% tras colaboración con NVIDIA

Do Options Traders Know Something About Simulations Plus Stock We Don't?

Cadence Q1 Earnings Top Estimates, 2026 Revenue Outlook Raised

Iridium's Q1 Earnings Miss Estimates, Revenues Increase Y/Y

SAP's Q1 Earnings & Revenues Up Y/Y on Cloud Momentum & AI Tailwinds

Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock Dips

Simulations Plus: Down Substantially, Not An Automatic Buy (NASDAQ:SLP)

Simulations Plus Q2 Earnings & Revenues Beat, Jump Y/Y, Shares Soar

TD Cowen reduce precio objetivo de Simulations Plus por inquietudes fiscales

5 acciones en el foco este viernes: LOT, SLP, PLCE, WDFC y FGI | Benzinga España

Simulations Plus, Inc. (SLP) Q2 2026 Earnings Call Transcript